MAS063DP is Effective Monotherapy for Mild to Moderate Atopic Dermatitis in Infants and Children: A Multicenter, Randomized, Vehicle-Controlled Study

Journal of Pediatrics

Volumn 152, Issue 6, 2008, Pages 854-859

  Boguniewicz, Mark ^a   Zeichner, Joshua A ^b   Eichenfield, Lawrence F ^c   Hebert, Adelaide A ^d   Jarratt, Michael ^e   Lucky, Anne W ^f   Paller, Amy S ^g  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c RADY CHILDREN'S HOSPITAL   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^e DermResearch Inc   (United States)

^f Dermatology Research Associates   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPICLAIR; DERMATOLOGICAL AGENT; DRUG VEHICLE; MAS 063DP;

ABNORMAL SENSATION; ARTICLE; ATOPIC DERMATITIS; BURN; CAREGIVER; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FEVER; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STINGING; TREATMENT RESPONSE;

CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DIETARY FATS; DOSAGE FORMS; DOUBLE-BLIND METHOD; FEMALE; GLYCYRRHETINIC ACID; HUMANS; INFANT; MALE; PLANT EXTRACTS; SEVERITY OF ILLNESS INDEX; VEHICLES;

EID: 43549098591     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2007.11.031     Document Type: Article

References (24)

1. Laughter D., Istvan J.A., Tofte S.J., and Hanifin J.M. The prevalence of atopic dermatitis in Oregon schoolchildren. J Am Acad Dermatol 43 (2000) 649-655
2. Chamlin S.L., Frieden I.J., Williams M.L., and Chren M.M. Effects of atopic dermatitis on young American children and their families. Pediatrics 114 (2004) 607-611
3. Akdis C.A., Akdis M., Bieber T., Bindslev-Jensen C., Boguniewicz M., Eigenmann P., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol 118 (2006) 152-169
4. Zuberbier T., Orlow S.J., Paller A.S., Tajeb A., Allen R., Hernanz-Hermosa J.M., et al. Patient perspectives on the management of atopic dermatitis. J Allergy Clin Immunol 118 (2006) 226-232
5. Berger T.G., Duvic M., Van Voorhees A.S., Van Beek M.J., and Frieden I.J. The use of topical calcineurin inhibitors in dermatology: safety concerns. Report of the American Academy of Dermatology Association Task Force. J Am Acad Dermatol 54 (2006) 818-823
6. Chamlin S.L., Kao J., Frieden I.J., Sheu M.Y., Fowler A.J., Fluhr J.W., et al. Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity. J Am Acad Dermatol 47 (2002) 198-208
7. Cork M.J., Robinson D.A., Vasilopoulos Y., Ferguson A., Moustafa M., MacGowan A., et al. New perspectives on epidermal barrier dysfunction in atopic dermatitis: Gene-environment interactions. J Allergy Clin Immunol 118 (2006) 3-21
8. Palmer C.N.A., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
9. Nomura T., Sandilands A., Akiyama M., Liao H., Evans A.T., Sakai K., et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119 (2007) 434-440
10. Vasilopoulos Y., Cork M.J., Murphy R., Williams H.C., Robinson D.A., Duff G.W., et al. Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol 123 (2004) 62-66
11. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., and Qutayba A.H. New insights in atopic dermatitis. J Clin Invest 113 (2004) 651-657
12. Spergel J.M., and Paller A.S. Atopic dermatitis and the atopic march. J Allergy Clin Immunol 112 (2003) S118-S127
13. Belloni G., Pinelli S., and Veraldi S. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 15 (2005) 31-36
14. Zhai H., Villarama C.D., Hafeez Z.H., and Maibach H.I. Efficacy of a topical agent MAS063D ('Atopiclair') in the treatment of sodium lauryl sulfate-induced irritant-contact dermatitis: a double-blind vehicle-controlled study. Exog Dermatol 2 (2003) 301-330
15. Abramovits W., Boguniewicz M., and Adult Atopiclair Study Group. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol 5 (2006) 236-244
16. Monder C., and White P.C. 11 beta-hydroxysteroid dehydrogenase. Vitam Horm 47 (1993) 187-271
17. Teelucksingh S., Mackie A.D., Burt D., Mcintyre M.A., Brett L., and Edwards C.R. Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 335 (1990) 1060-1063
18. Maffei Facino R., Carini M., Aldini G., Bombardelli E., Morazzoni P., and Morelli R. Free radicals scavenging action and anti-enzyme activities of procyanidines from Vitis vinifera. A mechanism for their capillary protective action. Arzneimittelforshung 44 (1994) 592-601
19. Grassi L., Moretti M., and Bisetti A. Un nuovo farmaco con attivita' antiproteasica: la telmesteina. Riv Ital Bil Med 12 (1992) 67-74
20. Manuskiatti W., and Maibach H.I. Hyaluronic acid and skin: wound healing and aging. Int J Derm 35 (1996) 539-544
21. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol 92 Suppl (1980) 44-47
22. Hanifin J.M., Thurston M., Omoto M., Cherill L., Tofte S.J., and Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol 10 (2001) 11-18
23. Segre J.A. Epidermal skin barrier formation and recovery in skin disorders. J Clin Invest 116 (2006) 1150-1158
24. Sigurjonsdottir H.A., Franzson L., Manhem K., Ragnarsson J., Sigurdsson G., and Wallerstedt S. Licorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens 15 (2001) 549-552